- Home
- ENSC vs PTPI Comparison
ENSC vs PTPI Comparison
Compare ENSC & PTPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENSC
- PTPI
- Stock Information
- Founded
- ENSC 2003
- PTPI 2020
- Country
- ENSC United States
- PTPI United States
- Employees
- ENSC N/A
- PTPI N/A
- Industry
- ENSC Biotechnology: Pharmaceutical Preparations
- PTPI Biotechnology: Pharmaceutical Preparations
- Sector
- ENSC Health Care
- PTPI Health Care
- Exchange
- ENSC Nasdaq
- PTPI Nasdaq
- Market Cap
- ENSC 2.9M
- PTPI 2.6M
- IPO Year
- ENSC N/A
- PTPI N/A
- Fundamental
- Price
- ENSC $3.29
- PTPI $0.05
- Analyst Decision
- ENSC
- PTPI
- Analyst Count
- ENSC 0
- PTPI 0
- Target Price
- ENSC N/A
- PTPI N/A
- AVG Volume (30 Days)
- ENSC 4.9M
- PTPI 8.9M
- Earning Date
- ENSC 05-12-2025
- PTPI 05-14-2025
- Dividend Yield
- ENSC N/A
- PTPI N/A
- EPS Growth
- ENSC N/A
- PTPI N/A
- EPS
- ENSC N/A
- PTPI N/A
- Revenue
- ENSC $5,210,031.00
- PTPI $5,112,043.00
- Revenue This Year
- ENSC N/A
- PTPI $9.25
- Revenue Next Year
- ENSC N/A
- PTPI N/A
- P/E Ratio
- ENSC N/A
- PTPI N/A
- Revenue Growth
- ENSC 133.58
- PTPI N/A
- 52 Week Low
- ENSC $1.62
- PTPI $0.04
- 52 Week High
- ENSC $14.67
- PTPI $0.77
- Technical
- Relative Strength Index (RSI)
- ENSC 55.92
- PTPI 42.67
- Support Level
- ENSC $3.02
- PTPI $0.05
- Resistance Level
- ENSC $4.85
- PTPI $0.06
- Average True Range (ATR)
- ENSC 0.40
- PTPI 0.01
- MACD
- ENSC 0.27
- PTPI 0.00
- Stochastic Oscillator
- ENSC 51.70
- PTPI 60.00
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
About PTPI Petros Pharmaceuticals Inc.
Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on therapeutics that promote medication adherence, tolerability, and preservation of male organic function. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Medical Devices segment. The Prescription Medications segment consists of operations related to vacuum erection devices, which are sold domestically and internationally.